Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	-83.85	-14.00	86.74
Graham Fair Price	39.54	4.33	3.11
PEG	-10.47	0.08	-0.09
Price/Book	14.53	2.67	2.33
Price/Cash Flow	25.80	-12.09	-16.29
Prices/Earnings	-46.84	8.36	15.72
Price/Sales	-22.18	1.17	1.50
Price/FCF	25.80	-12.09	-16.29
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	338.51	0.11	0.02
ROA	99.95	< 0.005	< 0.005
ROE	0.04	0.08	115.45
ROIC	0.02	0.08	370.65
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.20	-0.19	6.29
Dividends QOQ	0.94	-0.45	-52.63
EBIT QOQ	1.35	5.03	272.25
EPS QOQ	1.68	1.00	-40.62
FCF QOQ	0.29	-0.44	53.29
Revenue QOQ	8.11	0.37	-95.39
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.41	0.46	12.67
Quick Ratio	1.25	0.22	-82.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	3.40	3.23	-4.93
Cash	7.17	10.39	44.92
Capex	-0.02	-0.11	-363.89
Free Cash Flow	-0.49	-0.71	-46.73
Revenue	5.29	7.40	39.91
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	1.25	0.28	-77.66
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-132.75	9.37	-92.94
Naive Interpretation	Member

06 - Financial Health · Bad

Rating